KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EPS (Weighted Average and Diluted) (2019 - 2025)

Precigen (PGEN) has disclosed EPS (Weighted Average and Diluted) for 12 consecutive years, with -$0.01 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 83.33% to -$0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.34 through Dec 2025, down 179.17% year-over-year, with the annual reading at -$1.37 for FY2025, 191.49% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.01 at Precigen, up from -$1.06 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.44 in Q3 2022, with the low at -$1.06 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.16, with a median of -$0.1 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 438.46% in 2022, then crashed 1077.78% in 2025.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.22 in 2021, then crashed by 195.45% to -$0.65 in 2022, then skyrocketed by 80.0% to -$0.13 in 2023, then soared by 53.85% to -$0.06 in 2024, then skyrocketed by 83.33% to -$0.01 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.01, -$1.06, and -$0.09 for Q4 2025, Q3 2025, and Q2 2025 respectively.